PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 43 filers reported holding PROQR THRAPEUTICS N V in Q3 2020. The put-call ratio across all filers is 6.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | +90.0% | 14,689 | +124.9% | 0.00% | – |
| Q2 2023 | $10 | -94.5% | 6,530 | -92.4% | 0.00% | – |
| Q1 2023 | $183 | +40.8% | 86,152 | +143.6% | 0.00% | – |
| Q4 2022 | $130 | -87.0% | 35,365 | +1347.6% | 0.00% | – |
| Q3 2022 | $1,000 | – | 2,443 | +5581.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 43 | -99.7% | 0.00% | – |
| Q4 2021 | $130,000 | -83.9% | 16,291 | -86.7% | 0.00% | -100.0% |
| Q1 2021 | $807,000 | +6625.0% | 122,183 | +3990.5% | 0.00% | – |
| Q4 2020 | $12,000 | – | 2,987 | +18568.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 16 | -99.1% | 0.00% | – |
| Q2 2020 | $11,000 | -91.8% | 1,853 | -92.4% | 0.00% | – |
| Q1 2020 | $134,000 | – | 24,484 | +24384.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | +92.3% | 0.00% | – |
| Q1 2019 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |